Josep Gumà Padró (Josep Gumà-Padrò, J Gumà, Josep Gumà)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Diffuse Large B Cell Lymphoma

Lymph Node Metastasis

Top Venues

Future oncology (London, England)

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Llambrich, Pau Satorra, Eudald Correig, Josep Gumà Padró, Jesús Brezmes, Cristian Tebe, Raquel Cumeras
Easy-Amanida: An R Shiny application for the meta-analysis of aggregate results in clinical metabolomics using Amanida and Webchem. Research synthesis methods 15 (4) (2024)
Maria Llambrich, Pau Satorra, Eudald Correig, Josep Gumà Padró, Jesús Brezmes, Cristian Tebe, Raquel Cumeras
Easy-Amanida: An R Shiny application for the meta-analysis of aggregate results in clinical metabolomics using Amanida and Webchem. Research synthesis methods (2024)
Maria Llambrich, Pau Satorra, Eudald Correig, Josep Gumà Padró, Jesús Brezmes, Cristian Tebe, Raquel Cumeras
Easy-Amanida: An R Shiny application for the meta-analysis of aggregate results in clinical metabolomics using Amanida and Webchem. Research synthesis methods 15 (4) (2024)
Héctor Villalba, Maria Llambrich, Josep Gumà Padró, Jesús Brezmes, Raquel Cumeras
A Metabolites Merging Strategy (MMS): Harmonization to Enable Studies' Intercomparison. Metabolites 13 (12) (2023)
Héctor Villalba, Maria Llambrich, Josep Gumà Padró, Jesús Brezmes, Raquel Cumeras
A Metabolites Merging Strategy (MMS): Harmonization to Enable Studies' Intercomparison. Metabolites 13 (12) (2023)
Héctor Villalba, Maria Llambrich, Josep Gumà Padró, Jesús Brezmes, Raquel Cumeras
A Metabolites Merging Strategy (MMS): Harmonization to Enable Studies' Intercomparison. Metabolites 13 (12) (2023)
Josep Gumà Padró, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, Silvia Sequero, Virginia Calvo, Ramón García-Arroyo, José Gómez-Codina, Marta Llanos, Natividad Martínez-Banaclocha, Mariano Provencio
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Héctor Villalba, Maria Llambrich, Josep Gumà Padró, Jesús Brezmes, Raquel Cumeras
A Metabolites Merging Strategy (MMS): Harmonization to Enable Studies' Intercomparison. Metabolites 13 (12) (2023)
Josep Gumà Padró, Karla Peña, Francesc Riu, Carmen Guilarte, Anna Hernandez, Clara Lucía, Francisca Martínez-Madueño, Maria José Miranda, Inés Cabezas, Marc Grifoll, Sergio Peralta, Sara Serrano, Félix Muñoz, Lola Delamo, Barbara Roig, Joan Borràs, Joan Badia, Marta Rodriguez-Balada, David Parada
Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples. Cancers 14 (23) (2022)
Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà Padró, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez Carvajal, Jorge Labrador-Gomez, María Guirado-Risueño, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Espejo-García, Isabel Fernández-Román, Mariano Provencio Pulla, Margarita Sánchez-Beato, Marta Navarro, Marylène Lejeune, Tomás Álvaro-Naranjo, Maria Casanova-Espinosa, Víctor Sánchez-Margalet, Antonio Rueda-Domínguez, Luis de la Cruz Merino
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Karla Beatríz Peña, Francesc Riu, Josep Gumà Padró, Francisca Martínez-Madueño, Maria José Miranda, Anna Vidal, Marc Grifoll, Joan Badia, Marta Rodriguez-Balada, David Parada
Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study. Journal of clinical medicine 11 (24) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) (2022)
Karla Beatríz Peña, Francesc Riu, Josep Gumà Padró, Francisca Martínez-Madueño, Maria José Miranda, Anna Vidal, Marc Grifoll, Joan Badia, Marta Rodriguez-Balada, David Parada
Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study. Journal of clinical medicine 11 (24) (2022)
Karla Beatríz Peña, Francesc Riu, Josep Gumà Padró, Francisca Martínez-Madueño, Maria José Miranda, Anna Vidal, Marc Grifoll, Joan Badia, Marta Rodriguez-Balada, David Parada
Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study. Journal of clinical medicine 11 (24) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Josep Gumà Padró, Karla Peña, Francesc Riu, Carmen Guilarte, Anna Hernandez, Clara Lucía, Francisca Martínez-Madueño, Maria José Miranda, Inés Cabezas, Marc Grifoll, Sergio Peralta, Sara Serrano, Félix Muñoz, Lola Delamo, Barbara Roig, Joan Borràs, Joan Badia, Marta Rodriguez-Balada, David Parada
Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples. Cancers 14 (23) (2022)
Josep Gumà Padró, Karla Peña, Francesc Riu, Carmen Guilarte, Anna Hernandez, Clara Lucía, Francisca Martínez-Madueño, Maria José Miranda, Inés Cabezas, Marc Grifoll, Sergio Peralta, Sara Serrano, Félix Muñoz, Lola Delamo, Barbara Roig, Joan Borràs, Joan Badia, Marta Rodriguez-Balada, David Parada
Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples. Cancers 14 (23) (2022)
Ismael Fernández-Miranda, Lucía Pedrosa, Marta Llanos, Fernando F Franco, Sagrario Gómez, Paloma Martín-Acosta, Francisco R García-Arroyo, Josep Gumà Padró, Beatriz Horcajo, Ana K Ballesteros, Laura Gálvez Carvajal, Natividad Martínez-Banaclocha, Miguel Marín, Silvia Sequero, Marta Navarro, Natalia Yanguas-Casás, Virginia Calvo, Antonio Rueda Domínguez, Mariano Provencio Pulla, Margarita Sánchez-Beato
Monitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Karla Beatríz Peña, Francesc Riu, Josep Gumà Padró, Francisca Martínez-Madueño, Maria José Miranda, Anna Vidal, Marc Grifoll, Joan Badia, Marta Rodriguez-Balada, David Parada
Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study. Journal of clinical medicine 11 (24) (2022)
Karla B Peña, Francesc Riu, Josep Gumà Padró, Carmen Guilarte, Berta Pique, Anna Hernandez, Alba Àvila, Sandra Parra, Antoni Castro, Conxita Rovira, Pitter Cueto, Immaculada Vallverdu, David Parada
Study of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection-A Preliminary Report. Pathogens (Basel, Switzerland) 10 (7) (2021)
Jose Adriá-Cebrián, Sandra Guaita-Esteruelas, Eric Wing-Fai Lam, Marta Rodriguez-Balada, Jordi Capellades, Josefa Girona, Ana Maria Jimenez-Santamaria, Óscar Yanes, Lluis Masana, Josep Gumà Padró
MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature. Cancers 13 (23) (2021)
Marta Rodriguez-Balada, B Roig, Mireia Melé Olivé, M Salvat, Lourdes Martorell, J Borràs, Josep Gumà Padró
Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (9) (2018)
Bàrbara Roig, Marta Rodriguez-Balada, Sara Samino, Eric Wing-Fai Lam, Sandra Guaita-Esteruelas, Ana R Gomes, Xavier Correig, Joan Borràs, Óscar Yanes, Josep Gumà Padró
Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer. Scientific reports 7 (1) (2017)